InterCure to Participate in Upcoming Investor Conferences in May 2022
InterCure (NASDAQ: INCR), also known as Canndoc, announced participation in two investor conferences in May 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InterCure (NASDAQ: INCR), also known as Canndoc, announced participation in two investor conferences in May 2022. The conferences are:
- Canaccord Genuity 6th Annual Cannabis Conference on May 11, 2022
- Cowen 2nd Annual European Cannabis Conference on May 12, 2022
Management will engage in one-on-one meetings at these events. InterCure is recognized as the leading and fastest-growing cannabis company outside North America, with Canndoc being Israel's largest licensed cannabis producer.
Details
News Market Reaction – INCR
The recorded move for INCR in the trading session of this news was -4.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that that Alex Rabinovitch, Chief Executive Officer and Amos Cohen, Chief Financial Officer, will participate in the following investor conferences in May 2022.
Canaccord Genuity 6th Annual Cannabis Conference
Date: Wednesday, May 11, 2022
Cowen 2nd Annual European Cannabis Conference
Date: Thursday, May 12, 2022
InterCure's management team will be taking part in one-on-one meetings during the conferences. To schedule a one-on-one investor meeting with InterCure's management team, please contact a conference representative or adam@intercure.co.
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.
For more information, visit: http://www.intercure.co.
Contact:
InterCure Ltd.
Amos Cohen, Chief Financial Officer
amos@intercure.co
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.